HLA-C and neoplasm: By their extracellular domain, CAR-T cells recognize specific molecules on tumor cell membranes, while the intracellular domain triggers the T cell receptor (TCR) signaling activation, causing the death of target cells without the involvement of the major histocompatibility complex (MHC) molecules [32,33,34].